ArticleMolecular therapy : the journal of the American Society of Gene Therapy2025

Discovery and preclinical development of a potent epigenic editor targeting PCSK9 to lower LDL cholesterol.

Qiang Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.